You are using an older browser version. Please use a supported version for the best MSN experience.

WakeMed expands access to monoclonal antibody therapy

WakeMed is only the second provider in the state to join the national Crush COVID initiative, aimed at increasing access to this therapy
image beaconimage beaconimage beacon